PeptideDB

Anticancer agent 122

CAS: F: C18H15ClN2O2S W: 358.84

Anticancer agent 122, an inhibitor of human lactate dehydrogenase A enzyme (hLDHA), has good anticancer activities and c
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity Anticancer agent 122, an inhibitor of human lactate dehydrogenase A enzyme (hLDHA), has good anticancer activities and can be used for anticancer research[1].
Invitro Anticancer agent 122 (Compound 8m) (0-100 μM;72 小时) 抑制肝癌细胞 HepG2 细胞和宫颈癌细胞 SiHa 细胞生长,IC50 值分别为 5.15 μM 和 1.65 μM,且对人胚胎肾细胞系 HEK293 细胞无明显毒性[1]。 Cell Cytotoxicity Assay[1] Cell Line:
Name Anticancer agent 122
Formula C18H15ClN2O2S
Molar Mass 358.84
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Sharma D, et.al.Design and Synthesis of Thiazole Scaffold-Based Small Molecules as Anticancer Agents Targeting the Human Lactate Dehydrogenase A Enzyme. ACS Omega. 2023 May 10;8(20):17552-17562.